about
Obesity and hypertensive heart disease: focus on body composition and sex differencesCardiometabolic risk in overweight subjects with or without relative fat-free mass deficiency: the Strong Heart Study.Type of myocardial infarction presentation in patients with chronic kidney disease.Influence of Left Ventricular Stroke Volume on Incident Heart Failure in a Population With Preserved Ejection Fraction (from the Strong Heart Study).Validation of Left Atrial Volume Estimation by Left Atrial Diameter from the Parasternal Long-Axis View.Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patients with left ventricular hypertrophy the LIFE study.Depressed myocardial energetic efficiency is associated with increased cardiovascular risk in hypertensive left ventricular hypertrophy.Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network)Effect of diabetes and metabolic syndrome on myocardial mechano-energetic efficiency in hypertensive patients. The Campania Salute Network.Aortic root dimension and arterial stiffness in arterial hypertension: the Campania Salute Network.Classes of antihypertensive medications and blood pressure control in relation to metabolic risk factorsEvaluation of Unattended Automated Office, Conventional Office and Ambulatory Blood Pressure Measurements and Their Correlation with Target Organ Damage in an Outpatient Population of Hypertensives: Study Design and Methodological AspectsPoint-of-care ultrasound with pocket-size devices in emergency departmentUnattended Automated Office Blood Pressure Measurement and Cardiac Target Organ Damage, A Pilot StudyAutocrine Bradykinin Release Promotes Ischemic Preconditioning-Induced Cytoprotection in Bovine Aortic Endothelial Cells
P50
Q28073418-9FDD1091-FB7C-4A8D-B466-4CE29F52E73BQ37647845-567A8070-265D-448B-8F50-C35109B52021Q38419102-3436DC5D-562B-43E7-9B7E-50061D80C294Q38980303-7F977C34-410A-4D7C-A164-92EA60715956Q39042272-841AB2B6-801A-456C-9BE6-1DDAACDD9A91Q39317074-74452FD6-CE54-4554-B3EA-D5C3C776F11DQ40671715-14D21974-76C6-4960-8889-A8720A44D122Q41103777-5DFBE4D6-1D30-4875-8A1E-752D34E1E72AQ48050808-98E30E64-844C-4151-834D-3B55309CD8FAQ50907728-E529D513-D2B8-4442-BD56-39B5F1C060E1Q61868210-7E44FC96-9D14-4DF8-909A-3783CBF5B408Q90786610-F255B2DF-3993-41C0-A8A7-0D51FF061C08Q92496753-2EC58FA1-C076-41F4-93D4-9FF680740423Q92836062-6CCEC158-1B8E-42C0-870D-EB6E43C6DA92Q93262530-A41487A8-9AB1-4765-A36C-17D41D0516A4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
C Mancusi
@ast
C Mancusi
@en
C Mancusi
@es
C Mancusi
@nl
type
label
C Mancusi
@ast
C Mancusi
@en
C Mancusi
@es
C Mancusi
@nl
prefLabel
C Mancusi
@ast
C Mancusi
@en
C Mancusi
@es
C Mancusi
@nl
P106
P1153
36461425400
P31
P496
0000-0001-6690-1408